Alpha-toxin-elicited CX <sub>3</sub> CL1 release in <i>Staphylococcus aureus</i> pneumonia impairs bactericidal function of human monocytes

<i>Staphylococcus aureus</i> is an important human pathogen causing severe invasive infections. Pathogenesis is attributed to a wide array of virulence factors, including several potent exotoxins such as the pore-forming α-toxin. In this study, we found that patients with <i>S. aureus</i> respiratory tract infections had elevated CX<sub>3</sub>CL1 levels in airway fluid and plasma. Using human-organotypic lung models, we observed that stimulation of lung epithelium with α-toxin induces an intensified CX<sub>3</sub>CL1 expression apically in the epithelium as well as the release of CX<sub>3</sub>CL1. Blocking α-toxin or ADAM10 activity in organotypic lung using an α-toxin-blocking antibody or a specific ADAM10 inhibitor confirmed their role in modulating CX<sub>3</sub>CL1 cleavage and release. Analyses of CD14<sup>+</sup> human monocytes in combination with a CX<sub>3</sub>CR1 inhibitor revealed that α-toxin-mediated CX<sub>3</sub>CL1 release induces CX<sub>3</sub>CL1-dependent chemotaxis. In line with these data, lung tissue from patients with <i>S. aureus</i> respiratory tract infection showed elevated CX<sub>3</sub>CL1 and CD14 staining as compared with tissue from patients with non-infectious lung diseases. Functional studies of monocytes showed that CX<sub>3</sub>CL1 released by lung models resulted in upregulated CD83 and downregulated CD86, as well as impaired killing of phagocytosed <i>S. aureus</i>. Furthermore, stimulation of monocytes with soluble CX<sub>3</sub>CL1 hampered their reactive-oxygen and nitric-oxide production. Taken together our data show that <i>S. aureus</i> triggers the release of lung epithelial CX<sub>3</sub>CL1, and we identify an immunomodulatory effect of α-toxin involving its cytotoxic and ADAM10-interacting properties, inducing CX<sub>3</sub>CL1 release leading to impaired monocyte effector function.IMPORTANCEExotoxins are essential virulence factors for the pathobiont <i>S. aureus</i> and contribute toward severe invasive infections such as pneumonia. <i>S. aureus</i> α-toxin is a pore-forming exotoxin that causes host cell lysis and severe lung pathology. We found that α-toxin drives the release of membrane-bound chemokine CX<sub>3</sub>CL1 by involving ADAM10-mediated proteolytic activity. Furthermore, the release of CX<sub>3</sub>CL1 modulated immune responses locally, as demonstrated by enhanced monocyte migration and reduced capacity of monocytes to kill ingested bacteria. CX<sub>3</sub>CL1-induced reduction in bacterial killing coincided with impaired production of reactive oxygen and nitric oxide species. This reveals a novel mechanism in the pathogenesis of <i>S. aureus</i> lung infections involving α-toxin-induced release of CX<sub>3</sub>CL1, leading to impaired bacterial killing by monocytes.

Authors

Institutions

Publication Details

Journal
mBio
Published
2025-10-13
DOI
https://doi.org/10.1128/mbio.02689-25
Citations
2
Primary Topic
Antimicrobial Peptides and Activities
Type
article
Field-Weighted Citation Impact
2.37
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Alpha-toxin-elicited CX 3 CL1 release in Staphylococcus aureus pneumonia impairs bactericidal function of human monocytes

Danen Mootoosamy Cunoosamy, Kristoffer Strålin, Sara Cajander, Magda Lourda et al.
2 citations
mBio
Antimicrobial Peptides and Activities
2.37
article

Alpha-toxin-elicited CX 3 CL1 release in Staphylococcus aureus pneumonia impairs bactericidal function of human monocytes

Danen Mootoosamy Cunoosamy, Kristoffer Strålin, Sara Cajander, Magda Lourda, Markus Huemer, Tiziano A. Schweizer, Annelies S. Zinkernagel, Puran Chen, Taylor S. Cohen, Alejandro Gómez-Mejía, Samuel B. Berry, Volkan Özenci, Virginia Takahashi, Srikanth Mairpady Shambat, Rocky Barilla, Anna Norrby‐Teglund, Amanda Welin, Johanna Snäll, Mattias Svensson, Reto Schüpbach, Ewerton Marques Maggio
article en
2 citations

Abstract

<i>Staphylococcus aureus</i> is an important human pathogen causing severe invasive infections. Pathogenesis is attributed to a wide array of virulence factors, including several potent exotoxins such as the pore-forming α-toxin. In this study, we found that patients with <i>S. aureus</i> respiratory tract infections had elevated CX<sub>3</sub>CL1 levels in airway fluid and plasma. Using human-organotypic lung models, we observed that stimulation of lung epithelium with α-toxin induces an intensified CX<sub>3</sub>CL1 expression apically in the epithelium as well as the release of CX<sub>3</sub>CL1. Blocking α-toxin or ADAM10 activity in organotypic lung using an α-toxin-blocking antibody or a specific ADAM10 inhibitor confirmed their role in modulating CX<sub>3</sub>CL1 cleavage and release. Analyses of CD14<sup>+</sup> human monocytes in combination with a CX<sub>3</sub>CR1 inhibitor revealed that α-toxin-mediated CX<sub>3</sub>CL1 release induces CX<sub>3</sub>CL1-dependent chemotaxis. In line with these data, lung tissue from patients with <i>S. aureus</i> respiratory tract infection showed elevated CX<sub>3</sub>CL1 and CD14 staining as compared with tissue from patients with non-infectious lung diseases. Functional studies of monocytes showed that CX<sub>3</sub>CL1 released by lung models resulted in upregulated CD83 and downregulated CD86, as well as impaired killing of phagocytosed <i>S. aureus</i>. Furthermore, stimulation of monocytes with soluble CX<sub>3</sub>CL1 hampered their reactive-oxygen and nitric-oxide production. Taken together our data show that <i>S. aureus</i> triggers the release of lung epithelial CX<sub>3</sub>CL1, and we identify an immunomodulatory effect of α-toxin involving its cytotoxic and ADAM10-interacting properties, inducing CX<sub>3</sub>CL1 release leading to impaired monocyte effector function.IMPORTANCEExotoxins are essential virulence factors for the pathobiont <i>S. aureus</i> and contribute toward severe invasive infections such as pneumonia. <i>S. aureus</i> α-toxin is a pore-forming exotoxin that causes host cell lysis and severe lung pathology. We found that α-toxin drives the release of membrane-bound chemokine CX<sub>3</sub>CL1 by involving ADAM10-mediated proteolytic activity. Furthermore, the release of CX<sub>3</sub>CL1 modulated immune responses locally, as demonstrated by enhanced monocyte migration and reduced capacity of monocytes to kill ingested bacteria. CX<sub>3</sub>CL1-induced reduction in bacterial killing coincided with impaired production of reactive oxygen and nitric oxide species. This reveals a novel mechanism in the pathogenesis of <i>S. aureus</i> lung infections involving α-toxin-induced release of CX<sub>3</sub>CL1, leading to impaired bacterial killing by monocytes.

mBioVol. 16(11)
Brigham and Women's Hospital (US), Karolinska University Hospital (SE), University of Zurich (CH), Örebro University (SE), Karolinska Institutet (SE), Women's & Children's Health Research Institute (AU), University Hospital of Zurich (CH), Integrated Cardio Metabolic Centre (SE), AstraZeneca (France) (FR), AstraZeneca (Singapore) (SG), AstraZeneca (Switzerland) (CH), AstraZeneca (Finland) (FI)
Openalex Percentile: Top 10%
Antimicrobial Peptides and Activities
2.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.